Clinical Trials in Lugano, Switzerland

66 recruiting

Showing 120 of 89 trials

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study

Bleeding Disorder
University Hospital, Geneva400 enrolled7 locationsNCT05713734
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Not Applicable

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

Atrial FibrillationIschemic Stroke
Insel Gruppe AG, University Hospital Bern482 enrolled28 locationsNCT05976685
Recruiting
Phase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled596 locationsNCT07037459
Recruiting
Phase 3

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

ObesityOverweightAtherosclerotic Cardiovascular Disease
Amgen12,800 enrolled759 locationsNCT07037433
Recruiting
Phase 3

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Merck Sharp & Dohme LLC1,046 enrolled251 locationsNCT06717347
Recruiting
Phase 3

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting

Product Surveillance Registry

Cardiac Rhythm DisordersNeurological DisordersCardiovascular Disorders+1 more
Medtronic100,000 enrolled391 locationsNCT01524276
Recruiting

Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

Coronary Artery DiseaseAntiplatelet TherapyMinimally Invasive Coronary Revascularization Surgery
Cardiocentro Ticino30 enrolled1 locationNCT07514962
Recruiting
Phase 3

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen444 enrolled107 locationsNCT06700343
Recruiting
Phase 2

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Aortic Stenosis
Novartis Pharmaceuticals502 enrolled139 locationsNCT05646381
Recruiting
Phase 3

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Alzheimers Disease
Hoffmann-La Roche800 enrolled146 locationsNCT07170150
Recruiting
Phase 2

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Primary Biliary CholangitisPBC
Mirum Pharmaceuticals, Inc.260 enrolled130 locationsNCT05050136
Recruiting
Not Applicable

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Coronary Artery Disease
Teleflex150 enrolled17 locationsNCT06779630
Recruiting
Not Applicable

Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography

Acute Heart Failure
Antonio Leidi222 enrolled5 locationsNCT06465498
Recruiting
Phase 2

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring84 enrolled96 locationsNCT07332091
Recruiting

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Ulcerative Colitis
AbbVie400 enrolled94 locationsNCT05496348
Recruiting
Not Applicable

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland606 enrolled12 locationsNCT06958835
Recruiting
Phase 2

Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.

University Hospital, Basel, Switzerland75 enrolled9 locationsNCT06163573
Recruiting
Not Applicable

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

Virtual Reality
Schlotterbeck Hervé150 enrolled1 locationNCT06346132